Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Metastatic Pancreatic Adenocarcinoma · Stage IV Pancreatic Cancer AJCC v8

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Contact: Study coordinator (Anne Noonan, MD) · anne.noonan@osumc.edu · 614-685-6912
Contact: Principal Investigator (Anne Noonan, MD)

Study leads

Laith Abushahin, MBBS
Principal Investigator
Ohio State University Comprehensive Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma

Pancreatic Cancer · Adenocarcinoma of the Pancreas · Adenocarcinoma

Abroad (travel likely)RecruitingPHASE2

New York, United States · Providence, United States

iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation

KRAS NP_004976.2:p.G12D · Metastatic Pancreatic Adenocarcinoma · Pancreatic Ductal Adenocarcinoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Houston, United States

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Cancer, Metastatic · Cancer · Cancer of Pancreas

Abroad (travel likely)Recruiting

Birmingham, United States · Mobile, United States

Study of Amplitude-Modulated Radiofrequency Electromagnetic Fields in Metastatic Pancreatic Cancer

Pancreatic Cancer · Metastatic Adenocarcinoma

Abroad (travel likely)RecruitingPHASE2

Winston-Salem, United States